We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Pearson, 40p tax, BAE

Sun, 28th Oct 2012 19:28

News Corporation has joined the race for Penguin with a last-minute overture to the directors of Pearson, the media conglomerate that owns the book publisher. Glen Moreno, Pearson's chairman, will put the approach to directors in the next few days. Rupert Murdoch, the chairman and chief executive of News Corp, parent company of The Sunday Times, is understood to have indicated he will make a substantial cash offer ? thought to be about 1bn pounds ? for Penguin, subject to due diligence. A bid by News Corp, which owns one of Penguin's big rivals, Harper Collins, could torpedo the planned merger of Penguin and Random House, owned by Germany's Bertelsmann. Bertelsmann would own 60 per cent of the combined group, which would have nearly 30 per cent of English-language book sales. A union of Penguin and HarperCollins would have a market share of 20 per cent, according to The Sunday Times. In a statement on Sunday, Daily Mail and General Trust (DMGT) said: "In response to media speculation, DMGT confirms that it is currently in talks regarding the future of Northcliffe Media. "No deal or transaction has been agreed, but if these talks move to the point where agreement is reached, an announcement will be made to the market." The statement comes after reports this weekend that DMGT was in talks with David Montgomery, the former chief executive of Mirror Group, over a sale of its regional titles, valuing them at £110m. Mr Montgomery is thought to have secured private equity backing for the deal, which would see DMGT retain a substantial stake in the new venture, The Sunday Telegraph reports. There is ''reason for some optimism'' for the British economy over the coming period, according to Charlie Bean, Deputy Governor at the Bank of England. The economy has been ''bumping along the bottom'' for two years but there are now signs of progress in dealing with problems in the Eurozone and the banking system and expectations of lower inflation, he said. For his part, Chief Secretary to the Treasury Danny Alexander rejected suggestions that austerity is to blame for sluggish growth and said that he would still have backed cuts on the same scale, even if he knew at the time of the 2010 comprehensive spending review that growth over the subsequent two-and-a-half years would be just 0.6%, rather than the 6% that was forecast at the time, The Sunday Telegraph says. Telecoms giant BT, which shocked rivals in June with a £738m gamble on Premier League football, has struck deals for "hundreds" of live matches from Serie A in Italy, Ligue 1 in France and Brasileirao in Brazil. BT will use the matches to help beef up a new sports channel that will be launched next summer. In addition to the Premier League deal, which hands BT the rights to broadcast 38 live matches a year for three years from 2013, it has also signed a £152m deal to show Premiership Rugby for four years from next year. The outlay is thought to be close to £1bn. It is not known how much BT paid for its latest tranche of football rights. The move will put fresh pressure on rival BSkyB, which has built its empire on top-tier football rights and was caught off-guard by BT's entry into the market, The Sunday Telegraph assures.The 40p tax threshold should be raised to £50,000 to stop 1.3m people falling into the higher rate net, a report claims. A dramatic rise in the level at which people pay 40% tax should be brought in to reverse years of dragging more people into paying it, Conservative MPs Kwasi Kwarteng and Priti Patel argue. The 40p tax threshold is due to fall again to £41,450 next year, for most earners, from its current £42,475 level. But in a paper called Motivating The Middle, to be published tomorrow, Mr Kwarteng and Ms Patel will argue for a dramatic turnaround on the fiscal drag that has pulled more people into the 40p tax net. This drag has happened through the threshold rising slower than earnings under New Labour and the level at which 40p tax falls has then been lowered by Chancellor George Osborne as he raises the tax-free personal allowance, says The Financial Mail on Sunday. The Financial Mail on Sunday has established that the mobile phones of three executives at Citigate - one of the leading financial public relations advisers - may have been hacked in 2005 and 2006. A senior Citigate source said he was told by his phone company, O2, that his mobile had been hacked over an extended period from 2005 and advised to contact the police. Several other senior personnel at the firm were told that their phones had also been hacked. 'It is something which could have damaged my professional reputation if word of a deal got out,' he said. A spokesman for Citigate said: 'We were told by our mobile provider around 18 months ago that police were investigating allegations that between 2005 to 2006 attempts by unauthorised parties may have been made to hack into three of our company mobile phones.'The chairman of BAE Systems has rebuffed suggestions that he will stand down as early as next May in the wake of the failed £28bn merger with EADS, the owner of Airbus. However, Dick Olver is expected to come under more pressure from shareholders in the coming weeks, City sources said. Olver, chairman of BAE for eight years, has come in for particular criticism from Invesco Perpetual, BAE's biggest shareholder with a 13.4% stake. Neil Woodford, head of investment at Invesco, also wants Sir Peter Mason, the senior independent director, to go. He is due to stand down in January. Invesco has been backed by Artemis and Henderson, which own a further 2% between them. Woodford is angry that BAE's management, led by Olver and Ian King, chief executive, pursued a risky merger instead of sticking to cutting costs and returning money to shareholders, The Sunday Times says. Britain's faltering nuclear renaissance will receive a boost this week when Hitachi, the Japanese engineering giant, unveils a £700m takeover of Horizon Nuclear Power. The blockbuster deal values Horizon, which has rights to build reactors at Wylfa, on Anglesey, and Oldbury, near Bristol, well beyond what analysts expected it to fetch. Ed Davey, the energy secretary, is expected to herald the deal as an endorsement of the government's policy of enticing developers with the tens of billions in subsidies. Hitachi is expected to provide lucrative roles for British suppliers. Eon and RWE, Horizon's German owners, put the joint venture up for sale in March, citing soaring costs. The plan to build up to six reactors ? three on each site ? was expected to cost at least £20bn. The Germans' withdrawal threw Whitehall's controversial low-carbon energy overhaul into chaos. The government has put the construction of atomic reactors at the heart of its plans to replace fossil-fuelled plants, The Sunday Times reports. Sir Christopher Gent is to stand down as chairman of Glaxo Smith Kline. The pharmaceutical giant has appointed headhunters to search for a successor to Gent, who has held the role since January 2005. He is unlikely to go soon, with City sources indicating one option would be for him to leave at the 2014 shareholder meeting. The exact timing will depend on the choice of replacement. Glaxo declined to comment. Gent, 64, is one of Britain's best-known businessmen. As chief executive of Vodafone, he helped to turn the group into a mobile phone powerhouse, engineering the £112bn purchase of its German rival Mannesmann ? the biggest overseas takeover by a British firm, The Sunday Times writes.AB
More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.